Drug‐induced Apoptotic Neurodegeneration in the Developing Brain

Brain Pathology - Tập 12 Số 4 - Trang 488-498 - 2002
John W. Olney1, David F. Wozniak1, Vesna Jevtović‐Todorović2, Nuri B. Farber1, Petra Bittigau3, Chrysanthy Ikonomidou3
1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO
2Department of Anesthesiology, University of Virginia Health System, Charllottesville.
3Department of Pediatric Neurology, Charité‐Virchow Clinics, Humboldt University, Berlin, Germany

Tóm tắt

Physiological cell death (PCD), a process by which redundant or unsuccessful neurons are deleted by apoptosis (cell suicide) from the developing central nervous system, has been recognized as a natural phenomenon for many years. Whether environmental factors can interact with PCD mechanisms to increase the number of neurons undergoing PCD, thereby converting this natural phenomenon into a pathological process, is an interesting question for which new answers are just now becoming available. In a series of recent studies we have shown that 2 major classes of drugs (those that block NMDA glutamate receptors and those that promote GABAA receptor activation), when administered to immature rodents during the period of synaptogenesis, trigger widespread apoptotic neurodegeneration throughout the developing brain. In addition, we have found that ethanol, which has both NMDA antagonist and GABAmimetic properties, triggers a robust pattern of apoptotic neurodegeneration, thereby deleting large numbers of neurons from many different regions of the developing brain. These findings provide a more likely explanation than has heretofore been available for the reduced brain mass and lifelong neurobehavioral disturbances associated with the human fetal alcohol syndrome (FAS). The period of synaptogenesis, also known as the brain growth spurt period, occurs in different species at different times relative to birth. In rats and mice it is a postnatal event, but in humans it extends from the sixth month of gestation to several years after birth. Thus, there is a period in pre‐ and postnatal human development, lasting for several years, during which immature CNS neurons are prone to commit suicide if exposed to intoxicating concentrations of drugs with NMDA antagonist or GABAmimetic properties. These findings are important, not only because of their relevance to the FAS, but because there are many agents in the human environment, other than ethanol, that have NMDA antagonist or GABAmimetic properties. Such agents include drugs that may be abused by pregnant mothers (ethanol, phencyclidine [angel dust], ketamine [Special K], nitrous oxide [laughing gas], barbiturates, benzodiazepines), and many medicinals used in obstetric and pediatric neurology (anticonvulsants), and anesthesiology (all general anesthetics are either NMDA antagonists or GABAmimetics).

Từ khóa


Tài liệu tham khảo

10.1126/science.7939669

10.1111/j.1530-0277.2001.tb02210.x

10.1016/0006-8993(77)90310-9

10.1001/archpsyc.1991.01810350036005

10.1016/S0006-3223(01)01084-8

Bittigau P, 1998, Modeling periatric trauma: Mechanisms of neurodegeneration and potential strategies for neuroprotection, Restorative Neurology and Neuro-science, 13, 11

10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P

10.1111/j.1530-0277.1990.tb00455.x

10.1097/00001756-199512000-00014

10.1016/S0022-3476(78)80072-9

10.1080/09553009214551201

10.1016/S0006-8993(96)01347-9

10.1016/0006-8993(71)90130-2

10.1080/080352500750027808

Dikranian K, 2000, Histological characterization of apoptotic neurodegeneration induced in the developing rat brain by drugs that block sodium channels, Soc Neurosci Abst, 26, 323

10.1006/nbdi.2001.0411

10.1016/0378-3782(79)90022-7

10.1097/00001756-199412000-00070

10.1016/S0301-0082(98)00027-6

10.1176/ajp.155.4.552

10.1016/0006-3223(95)00046-1

Farber NB, 1999, Action of ethanol at GABAA receptors blocks neurotoxicity in the adult brain, but augments neurotoxicity in the developing brain, Soc Neurosci Abst, 25, 551

10.1002/ddr.430320304

Grasl‐Kraupp B, 1995, In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note, Hepatology, 21, 1465, 10.1016/0270-9139(95)90071-3

10.1016/S0306-4522(96)00473-3

10.1111/j.1530-0277.1995.tb01496.x

Hartman RE, 2001, Neonatal exposure to common anesthetics leads to spatial learning deficits in juvenile rats, Soc Neurosci Abs, 27, 398

10.1111/j.1471-4159.1989.tb07280.x

10.1016/S0006-8993(96)01290-5

10.1203/00006450-199606000-00015

10.1126/science.283.5398.70

10.1126/science.287.5455.1056

10.1126/science.288.5468.976

Ikonomidou C, 2000, Antiepileptic drugs which block sodium channels cause neuronal apoptosis in the developing rat brain, Soc Neurosci Abst, 26, 323

10.1016/0304-3940(95)11650-L

10.1002/(SICI)1096-9861(19990614)408:4<461::AID-CNE2>3.0.CO;2-9

10.1097/00004647-199702000-00006

10.1038/nm0498-460

Jevtovic‐Todorovic V, 2001, Commonly used anesthesia protocol causes neuronal suicide in the immature rat brain, Soc Neurosci Abst, 27, 398

10.1016/S0140-6736(73)91092-1

10.1002/tera.1420120102

10.1016/S0140-6736(73)91291-9

10.1177/002221949703000612

10.1038/bjc.1972.33

10.1038/sj.mp.4000529

10.1126/science.2467382

10.1523/JNEUROSCI.18-23-09716.1998

10.1385/MN:22:1-3:041

10.1126/science.2660263

10.1126/science.1835799

Olney JW, 1999, Ethanol induces widespread apoptotic neurodegeneration in the infant mouse brain, Soc Neurosci Abst, 25, 550

10.1016/S0165-3806(02)00279-1

10.1006/nbdi.2001.0475

Pierce DR, 1987, Severity of alcohol‐induced deficits in rats during the third trimester equivalent is determined by the pattern of exposure, Alcohol, 461

10.1073/pnas.96.5.2508

Samson HH, 1986, Alcohol and brain development, 167

Sapp DW, 1998, Ethanol‐GABA(A) receptor interactions: a comparison between cell lines and cerebellar Purkinje cells, J Pharmacol Exp Ther, 284, 768

10.1002/cne.903300305

Stratton K, 1996, Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention and Treatment

10.1053/scnp.2000.6729

10.1126/science.6795717

10.1542/peds.99.2.232

10.1006/nbdi.1998.0206

Thông tin
Thông tin xuất bản

Brain Pathology

Tập 12 Số 4

488-498

Thông tin tác giả